Since obesity always co-occurs with dyslipidemia, the changes in the metabolism of adipocyte, owing to the polymorphisms in the SREBP2 gene and/or INSIG2, may lead to obesity and/or dyslipidemia. Here, INSIG2 is linked to metabolic syndrome.